Eris Lifesciences has informed that it enclosed a Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2023, received from Link lntime India, Registrar and Share Transfer Agent (RTA) of the Company. The company has certified and confirmed the same.
The above information is a part of company’s filings submitted to BSE.